Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. - Wikidata - wikimedia - TriplyDB

Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.

Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.

http://www.wikidata.org/entity/Q44068705

about

Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repair Primary glia expressing the G93A-SOD1 mutation present a neuroinflammatory phenotype and provide a cellular system for studies of glial inflammation Therapeutic neuroprotective agents for amyotrophic lateral sclerosis Serine racemase: a key player in apoptosis and necrosis A perspective on stem cell modeling of amyotrophic lateral sclerosis Reduction of circulating endothelial cells in peripheral blood of ALS patients Translational research involving oxidative stress and diseases of aging.Identification of B6SJL mSOD1(G93A) mouse subgroups with different disease progression rates.Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose.Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis.The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis Deregulated expression of cytoskeleton related genes in the spinal cord and sciatic nerve of presymptomatic SOD1(G93A) Amyotrophic Lateral Sclerosis mouse model.Inflammation in ALS and SMA: sorting out the good from the evil.Axotomy-induced target disconnection promotes an additional death mechanism involved in motoneuron degeneration in amyotrophic lateral sclerosis transgenic mice.Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.Expression of a pathogenic mutation of SOD1 sensitizes aprataxin-deficient cells and mice to oxidative stress and triggers hallmarks of premature ageing.Progress in therapy development for amyotrophic lateral sclerosis Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model.Thalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of Inflammation Molecular and cellular pathways of neurodegeneration in motor neurone disease Death Receptors in the Selective Degeneration of Motoneurons in Amyotrophic Lateral Sclerosis.Dysregulated expression of death, stress and mitochondrion related genes in the sciatic nerve of presymptomatic SOD1(G93A) mouse model of Amyotrophic Lateral Sclerosis.Identification of pharmacological targets in amyotrophic lateral sclerosis through genomic analysis of deregulated genes and pathways.RNAseq Analyses Identify Tumor Necrosis Factor-Mediated Inflammation as a Major Abnormality in ALS Spinal Cord.Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.Type I Vs. Type II Cytokine Levels as a Function of SOD1 G93A Mouse Amyotrophic Lateral Sclerosis Disease Progression.Current and future directions in genomics of amyotrophic lateral sclerosis.Use of biomarkers in ALS drug development and clinical trials Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-α, IL-6, and IL-10 in the spinal cord and serum of mice.Antioxidants in central nervous system diseases: preclinical promise and translational challenges.Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trial T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes Glial cells in amyotrophic lateral sclerosis Endothelial and Astrocytic Support by Human Bone Marrow Stem Cell Grafts into Symptomatic ALS Mice towards Blood-Spinal Cord Barrier Repair Cardiovascular disease and diagnosis of amyotrophic lateral sclerosis: A population based study.Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model Proximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to Neurodegeneration Formation of multinucleated giant cells and microglial degeneration in rats expressing a mutant Cu/Zn superoxide dismutase gene.

P2860

Q21245232-484FA738-6D9A-4EF9-AB6B-214498EF473B Q21284516-2E9E766C-F1EC-41B8-A115-0A55A000BF78 Q25256714-A8657E66-6598-4D24-A56D-8B4441E901B6 Q27015029-09F31EF3-44DA-4008-BADB-50AC811C8F35 Q27025560-309202F4-DF61-4CCF-8F53-D9D72220AA59 Q28080614-28C6A729-C48B-4CB6-A07C-AE33B2509235 Q28752226-180BB178-D60A-4898-B1BE-5059B93E3C42 Q30464085-CA43FFAF-280C-438C-83E8-C44F479ACAB1 Q30668718-319B7F0F-293D-4DBD-8F84-66D304564868 Q33346297-DA12A35E-6584-4378-8954-8741DEE08D5C Q33500473-57D71A8B-9096-4097-8EDB-B5993277F57C Q33633778-130C458D-63B3-4441-8E7B-D6B0D25E7E90 Q33659976-E4E747E6-372C-4F21-A3E8-3D53FDDEE9C4 Q33664711-E9FF6F42-EA68-4BE6-8D82-36A6905A1F3D Q33714159-233A3548-81E2-43CB-86B9-C5561205874F Q33919781-4B7DA70E-93C2-40C0-8A92-A3614E14A9DE Q34441404-8AFE2EF0-45B5-421C-B314-50352B0368CE Q34640800-0AAA3E62-335F-4466-9840-CCD3E7720B97 Q34798823-8AA9B16B-7AC9-4514-B994-CD24EA6F8CF4 Q35121026-4D6979F1-9440-4440-839B-F7B06407CD69 Q35489359-706F253B-9488-4EBE-B217-66DE05D296E4 Q35623419-15547EF0-05D5-46A6-9802-BEB322DB329C Q36012034-1438967B-F092-42FE-B8ED-B1AEE359AEA9 Q36087937-FA3CDDA2-DD97-4F2B-8CA6-65AA39D22B99 Q36093828-F07F6B38-D8CF-4BF7-AADE-A26383E044F0 Q36330960-8156D7E4-B8E5-4939-9B4A-DED0CD6BE7F5 Q36332951-9643A613-491E-4898-8EEA-8613EE442D04 Q36473151-14A04560-9226-48B9-BD15-49B63CDA1F66 Q36733981-E68BC772-6B69-4740-BE1F-912D91E1B711 Q36934383-A2B84BDA-4FF4-47BB-8EDA-80F557D1C5CB Q37159979-75CF1615-DA37-4AFF-9133-DB820AAC71BC Q37288200-32CEC62C-2546-40C6-8E1E-A4A3F3953631 Q37625319-AA6AC181-409B-4173-8529-2D8F63D346D9 Q37794395-8ACD43A6-2FCC-452C-AE1E-724326C1683D Q37902077-B344D302-A9B2-4B3C-A4CC-CCBCE6989149 Q38730523-D52DCA35-5011-4914-A79E-E3762B0B4F44 Q40642266-BA2902FD-D204-4A94-9454-4C8B8028F08F Q41573357-9D5290C7-7103-4259-8F32-0B2D45587859 Q41613567-024B990E-AD27-4E54-9A45-03B0B242CEE7 Q41832311-A023E70A-0491-4EB0-A794-FF2FEDB5EC42

P2860

Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.

http://www.wikidata.org/entity/Q44068705

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Temporal patterns of cytokine ...... amyotrophic lateral sclerosis.

@en

Temporal patterns of cytokine ...... amyotrophic lateral sclerosis.

@nl

type

label

Temporal patterns of cytokine ...... amyotrophic lateral sclerosis.

@en

Temporal patterns of cytokine ...... amyotrophic lateral sclerosis.

@nl

prefLabel

Temporal patterns of cytokine ...... amyotrophic lateral sclerosis.

@en

Temporal patterns of cytokine ...... amyotrophic lateral sclerosis.

@nl

P1433

Q44068705-920289D1-EDA7-4769-A660-68248B384BBC

P1476

Q44068705-ADFC1E37-2543-4B66-94DD-DE66FD64EE4F

P2093

Q44068705-21AF2D9B-A8A9-4942-BE4B-E33CE047D6F4

Q44068705-4FCF4828-C145-4B35-B281-48F9D1F144CF

Q44068705-50EDDC06-1B74-4CBD-A9C1-71776941F648

Q44068705-788C7A93-3769-4ED1-B28A-99D3B0A7EF21

Q44068705-7AB64598-5EF6-4D8D-A0B8-E65325A0C866

Q44068705-ACDE97B9-A017-4251-8040-CE05412B89AC

Q44068705-D9519FD0-6908-4F18-BA9C-0DC773A053B9

Q44068705-EB559842-4FBE-41FB-897C-F51E8E8769D5

P304

Q44068705-2C8B1911-E3E1-42FD-A062-4D31E379CC3B

P31

Q44068705-BF4FE671-C818-464A-A640-F22873E69F8B

P356

Q44068705-92F6853E-533E-4324-82FC-ED290C0FD221

P407

Q44068705-A404F7ED-08B1-4B62-A610-8A52F1F28FA5

P433

Q44068705-0A5AECF1-E458-4469-A43A-2C49BDB6AB27

P478

Q44068705-88FB68FF-D80C-4B46-82B8-B40600486C45

P577

Q44068705-5B00DB3A-38D5-4817-B188-3E23B8854469

P698

Q44068705-889C84E0-8F63-4C9A-AD27-AA2335BA5B0C

P921

Q44068705-EF2F71D4-EFE0-44FC-A5D5-B39CB0FB9C36

P356

J.1471-4159.2002.00968.X

P1433

Journal of Neurochemistry

P1476

Temporal patterns of cytokine ...... amyotrophic lateral sclerosis

@en

P2093

Brian Gordon

http://www.w3.org/2001/XMLSchema#string

Charles Stewart

http://www.w3.org/2001/XMLSchema#string

Kelly Williamson

http://www.w3.org/2001/XMLSchema#string

Kenneth Hensley

http://www.w3.org/2001/XMLSchema#string

Melinda West

http://www.w3.org/2001/XMLSchema#string

Quentin N Pye

http://www.w3.org/2001/XMLSchema#string

Robert A Floyd

http://www.w3.org/2001/XMLSchema#string

Shenyun Mou

http://www.w3.org/2001/XMLSchema#string

P304

365-374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1471-4159.2002.00968.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12124437

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis